TIGIT and neoplasm: In the tumor infiltrate, T cells and NK cells are affected by AIF1, which promotes TIGIT expression, and hence induces or strengthens immunotherapy resistance sustained by an immune infiltrate enriched in Th1 cells and exhausted T cells.